Search Results 371-380 of 18864 for Neutrophil

  1. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    - Absolute neutrophil count (ANC) > 1000/µL - Absolute lymphocyte count > 100/µL - Platelet count > 50,000/µL - Estimated life expectancy of more than 3 ...

  2. A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

    Absolute neutrophil count ≥ 1.5 × 10^9 /L;; Platelets ≥ 100 × 10^9 /L;; Hemoglobin ≥ 9 g/dl;; Serum creatinine ≤ 1.5mg/dL or estimated creatinine clearance ...

  3. A Study Using Avelumab in Non-Small Cell Lung Cancer that has Progressed - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1.5 × 10^9/L; Lymphocyte count ≥ 0.5 × 10^9/L; Platelet count ≥ 100 × 10^9/L; And hemoglobin ≥ 9 gram per deciliter (g/dL).

  4. A Study of MK-1026 in Patients with Selected Hematologic Malignancies - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1000/µL;; Hemoglobin (Hgb) ≥ 8.0 g/dL, stable for ≥ 1 week. For men and women of child-bearing potential, willing to use ...

  5. Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/​Refractory T-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Life expectancy greater than 6 months. Patients must have normal organ and marrow function as defined below: Leukocytes ≥ 3,000/μL; Absolute neutrophil count ...

  6. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

    Absolute neutrophil count (ANC) ≥1000/mm3 (neutropenia due to marrow infiltration may be supported by GCSF). Transfusion and/or growth factor support is ...

  7. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

    Absolute neutrophil count (ANC) >=1.0 X 10^9/L;; Hemoglobin >=8.0 g/dL;; Platelets>= 50 X 10^9/L;; Total bilirubin <=1.5X Upper limit of normal (ULN). Isolated ...

  8. Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer - Mayo Clinic

    absolute neutrophil count ≥1,500/mcL; platelets ≥100,000/mcL; total bilirubin <1.5 X upper normal institutional limit; AST(SGOT)/ALT(SGPT) ≤2.5 X ...

  9. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1,000 cells/mm^3 (without transfusion or growth factor support within 14 days prior to registration). Participants with ...

  10. Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) - Mayo Clinic

    Absolute neutrophil count ≥ 1,500/mcL. 10. Platelets ≥ 100,000/mcL. 11. Total bilirubin ≤ 2 x ULN. (≤ 3 x ULN for potential subjects with Gilbert's